Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s10020-020-00263-2
Saved in:
Main Authors: | Karin Palmblad (Author), Hanna Schierbeck (Author), Erik Sundberg (Author), Anna-Carin Horne (Author), Helena Erlandsson Harris (Author), Jan-Inge Henter (Author), Daniel J. Antoine (Author), Ulf Andersson (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
by: Karin Palmblad, et al.
Published: (2020) -
Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
by: Karin Palmblad, et al.
Published: (2021) -
Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
by: Huan Yang, et al.
Published: (2020) -
Redox modifications of cysteine residues regulate the cytokine activity of HMGB1
by: Huan Yang, et al.
Published: (2021) -
Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
by: Huan Yang, et al.
Published: (2020)